MicroRNA-451 regulates activating transcription factor 2 expression and inhibits liver cancer cell migration

Oncology Reports

Volumn 32, Issue 3, 2014, Pages 1021-1028

  Lv, Guixiang ^a,b   Hu, Zheng ^a,c   Tie, Yi ^a   Du, Jingli ^d   Fu, Hanjiang ^a   Gao, Xu ^b   Zheng, Xiaofei ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c HARBIN INSTITUTE OF TECHNOLOGY   (China)

^d CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Activating transcription factor 2; Liver cancer; Migration; MiR 451

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; MICRORNA; MICRORNA 451; UNCLASSIFIED DRUG; ATF2 PROTEIN, HUMAN; MIRN451 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL MIGRATION; CELL NUCLEUS; CELL STRAIN; CELL STRAIN SK HEP 1; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE FUNCTION; HEPG2 CELL LINE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN RNA BINDING; TRANSCRIPTION REGULATION; CELL MOTION; GENETICS; LIVER TUMOR; PATHOLOGY; TUMOR CELL LINE;

ACTIVATING TRANSCRIPTION FACTOR 2; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; DOWN-REGULATION; FEMALE; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED;

EID: 84923068131     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3296     Document Type: Article

References (35)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-917, 2010.
2. Sun H, Wei Y, Tu H, et al: Expressions of COX-2, PKC-alpha and miR-101 in gastric cancer and their correlations. Nan Fang Yi Ke Da Xue Xue Bao 33: 559-562, 2013 (In Chinese).
3. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
4. Lujambio A and Lowe SW: The microcosmos of cancer. Nature 482: 347-355, 2012.
5. Augello C, Vaira V, Caruso L, et al: MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma. Liver Int 32: 772-782, 2012.
6. Ying Q, Liang L, Guo W, et al: Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma. Hepatology 54: 2064-2075, 2011.
7. Fornari F, Gramantieri L, Giovannini C, et al: MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res 69: 5761-5767, 2009.
8. Qu KZ, Zhang K, Li H, Afdhal NH and Albitar M: Circulating microRNAs as biomarkers for hepatocellular carcinoma. J Clin Gastroenterol 45: 355-360, 2011.
9. Tomimaru Y, Eguchi H, Nagano H, et al : Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. J Hepatol 56: 167-175, 2012.
10. Liu Q, Fu H, Sun F, et al: miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res 36: 5391-5404, 2008.
11. Fu HJ, Zhu J, Yang M, et al: A novel method to monitor the expression of microRNAs. Mol Biotechnol 32: 197-204, 2006. (Pubitemid 43787131)
12. Bagga S, Bracht J, Hunter S, et al: Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 122: 553-563, 2005. (Pubitemid 41191154)
13. Lim LP, Lau NC, Garrett-Engele P, et al: Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773, 2005. (Pubitemid 40292988)
14. Mathonnet G, Fabian MR, Svitkin YV, et al: MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science 317: 1764-1767, 2007. (Pubitemid 47461843)
15. Lau E, Kluger H, Varsano T, et al: PKCepsilon promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria. Cell 148: 543-555, 2012.
16. Wang XC, Tian LL, Jiang XY, et al: The expression and function of miRNA-451 in non-small cell lung cancer. Cancer Lett 311: 203-209, 2011.
17. Zhang J, Yang Y, Yang T, et al: microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br J Cancer 103: 1215-1220, 2010.
18. Ji J, Zhao L, Budhu A, et al: Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. J Hepatol 52: 690-697, 2010.
19. Xiong Y, Fang JH, Yun JP, et al: Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 51: 836-845, 2010.
20. Yang JS, Maurin T, Robine N, et al: Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated microRNA biogenesis. Proc Natl Acad Sci USA 107: 15163-15168, 2010.
21. Wang R, Wang ZX, Yang JS, Pan X, De W and Chen LB: MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene 30: 2644-2658, 2011.
22. Godlewski J, Nowicki MO, Bronisz A, et al: MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to 23. Godlewski J, Bronisz A, Nowicki MO, Chiocca EA and Lawler S: microRNA-451: A conditional switch controlling glioma cell proliferation and migration. Cell Cycle 9: 2742-2748, 2010.
23. Bergamaschi A and Katzenellenbogen BS: Tamoxifen down-regulation of miR-451 increases 14-3-3 ζ and promotes breast cancer cell survival and endocrine resistance. Oncogene 31: 39-47, 2012.
24. Gal H, Pandi G, Kanner AA, et al: miR-451 and imatinib mesylate inhibit tumor growth of glioblastoma stem cells. Biochem Biophys Res Commun 376: 86-90, 2008.
25. Hai T and Hartman MG: The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 273: 1-11, 2001. (Pubitemid 32718721)
26. Breitwieser W, Lyons S, Flenniken AM, et al : Feedback regulation of p38 activity via ATF2 is essential for survival of embryonic liver cells. Genes Dev 21: 2069-2082, 2007. (Pubitemid 47267292)
27. Eferl R and Wagner EF: AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3: 859-868, 2003. (Pubitemid 37383716)
28. Bhoumik A, Gangi L and Ronai Z: Inhibition of melanoma growth and metastasis by ATF2-derived peptides. Cancer Res 64: 8222-8230, 2004. (Pubitemid 39491759)
29. Bhoumik A, Huang TG, Ivanov V, et al: An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis. J Clin Invest 110: 643-650, 2002. (Pubitemid 34988788)
30. Bhoumik A, Fichtman B, Derossi C, et al: Suppressor role of activating transcription factor 2 (ATF2) in skin cancer. Proc Natl Acad Sci USA 105: 1674-1679, 2008. (Pubitemid 351346573)
31. Vale-Cruz DS, Ma Q, Syme J and LuValle PA: Activating transcription factor-2 affects skeletal growth by modulating pRb gene expression. Mech Dev 125: 843-856, 2008.
32. Nakamura T, Okuyama S, Okamoto S, Nakajima T, Sekiya S and Oda K: Down-regulation of the cyclin A promoter in differentiating human embryonal carcinoma cells is mediated by depletion of ATF-1 and ATF-2 in the complex at the ATF/CRE site. Exp Cell Res 216: 422-430, 1995.
33. Berger AJ, Kluger HM, Li N, et al: Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survival. Cancer Res 63: 8103-8107, 2003. (Pubitemid 37549453)
34. Choi JH, Cho HK, Choi YH and Cheong J: Activating transcription factor 2 increases transactivation and protein stability of hypoxia-inducible factor 1alpha in hepatocytes. Biochem J 424: 285-296, 2009.
35. Song H, Ki SH, Kim SG and Moon A: Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells. Cancer Res 66: 10487-10496, 2006. (Pubitemid 44799770)